🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single-arm, open-label, exploratory study to evaluate efficacy an...
Status
Unknown
Location
The Affiliated Hospital of Xuzhou Medical University
Start Date
2022-04-01
Trial ID
NCT05298020
Treatments Being Tested
To evaluate the effectiveness, safety and tolerability of Endostar (recombi...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2020-09-01
Trial ID
NCT04699214
Treatments Being Tested
A Study to Assess the Effects of Durvalumab following Rh-Endostatin combine...
Status
Unknown
Location
Multiple Locations
Start Date
2020-12-01
Trial ID
NCT04613284
Treatments Being Tested
The main purpose of this clinical study is to see if a maintenance dose of ...
Status
Terminated
Location
University of Alabama Birmingham
Start Date
2017-05-24
Trial ID
NCT03146403
Treatments Being Tested
This is a randomized, double-blind, factorial study to compare the reductio...
Status
Completed
Location
University of Alabama Vaccine Research Unit
Start Date
2014-07
Trial ID
NCT02114060
This is an open, non comparative, multicentre phase II trial, to evaluate t...
Status
Completed
Location
Facultni nemocnice
Start Date
2014-12
Trial ID
NCT02329080
This is a voluntary study to allow subjects who received placebo while on G...
Status
Completed
Location
University of Alabama Vaccine Research Unit
Start Date
2015-01
Trial ID
NCT02300142
To evaluate the efficacy and safety of recombinant human endostatin (Endost...
Status
Unknown
Location
The First Affiliated Hospital of Shandong First Medical University
Start Date
2021-02-01
Trial ID
NCT05574998
Treatments Being Tested
This is a prospective, single-arm, multicenter, phase II clinical study des...
Status
Recruiting
Location
Shandong Public Health Clinical Center (ShandongPHCC)
Start Date
2024-08-27
Trial ID
NCT06617936
This is a prospective, single arm, multicenter phase II study aimed at eval...
Status
Unknown
Location
Qilu hospital of Shandong univertisy
Start Date
2021-12-03
Trial ID
NCT05243355
Treatments Being Tested